IOnctura CEO On Pipeline Strategy And Funding Goals



IOnctura’s CEO Catherine Pickering outlines the company’s business model and its approach to cancer R&D targeting the tumor microenvironment. She talks to Scrip’s John Hodgson about the company’s founding, technology and checkpoint inhibitor com

No comments: